<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Calgary_BetaOxidation skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Calgary/BetaOxidation</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Header</TITLE></P><DIV class="nav-bar"><DIV id="TopBar"><DIV class="nav" class="nav"><A href="#" class="toggle-menu">☰</A><UL class="nav-list nav-open" id="nav"><LI><A href="https://2017.igem.org/Team:Calgary">Home</A></LI><LI><A href="#" class="toggle-drop">Project</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Description">Problem/Description</A></LI><LI><A href="#" class="toggle-drop2">Synthesis </A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Synthesis">Synthesis Overview</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/BetaOxidation">Beta Oxidation</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Glycolysis">Glycolysis</A></LI></UL><LI><A href="https://2017.igem.org/Team:Calgary/Secretion">Secretion</A></LI><LI><A href="#" class="toggle-drop2">Process  </A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Process">Process Overview</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/VFA_Fermentation">VFA Fermentation</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/SolidLiquidSeparation">Solid-Liquid Separation</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/PHB_Fermentation">PHB Fermentation</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Extraction">Extraction</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Products">Products</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Applied_Design">Applied Design</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Experiments">Experiments</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Composite_Part">Composite Parts</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Model">Modelling </A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Journal">Notebook</A></LI><LI><A href="#" class="toggle-drop">Team</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Team">Team Members</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Attributions">Attributions</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Sponsors">Sponsors</A></LI><LI><A href="#" class="toggle-drop">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Human_Practices">HP Summary</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/HP/Silver">HP Silver</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/HP/Gold_Integrated">HP Gold/Integrated HP</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Collaborations">Collaborations</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Engagement">Engagement</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/Safety">Safety</A></LI><LI><A href="#" class="toggle-drop">Judging</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/MedalRequirements">Medal Requirements</A></LI><LI><A href="https://2017.igem.org/Team:Calgary/InterLab">Interlab</A></LI></DIV></DIV></DIV><DIV id="MainContent"><H1>Beta-Oxidation</H1><H2>Aim</H2><P>The objective of this part of our project was to genetically engineer <I>E. coli</I> to produce PHB from volatile fatty acids (VFAs) found in human fecal waste. VFAs (acetic acid, propionic acid, butyric acid, and lactic acid) serve as precursors for the synthesis of PHB via the beta-oxidation pathway native to bacterial cells (Reyhanitash, 2017).</P><H2>Manipulation of the beta-oxidation pathway</H2><P>In order to synthesize PHB from fatty acids found in human fecal waste, we manipulated the fatty acid beta-oxidation pathway within <I>E. coli</I>. We designed a construct that contains the <I>phaJ4</I> gene from <I>Pseudomonas putida</I>, encoding for enoyl-CoA hydratase that converts the enoyl-CoA into (R)-hydroxybutyrate (Lu, 2003). Our construct also includes the <I>phaC1</I> gene from <I>Pseudomonas aeruginosa</I>, encoding the PHA synthase, which converts the (R)-hydroxyacyl-CoA into polyhydroxybutyrate (PHB). To our advantage, this pathway not only uses VFAs but can also use undigested long-chain fatty acids in human fecal waste, thus maximizing the substrates available for PHB synthesis.</P><H2>Genetic construct</H2><P><CENTER>Figure 1: Genetic construct for <A href="http://parts.igem.org/Part:BBa_K2260001">phaC1J4</A>, including the ribosomal binding sites (<A href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</A>) and the <I>phaJ</I> and <I>phaC</I> genes</CENTER></P><P>Our construct has been designed for translation in <I>E. coli</I>, as it contains the common strong RBS <A href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</A> in front of each gene, and codons have been optimized. We also ensured that our BioBrick was compatible with all iGEM RFC standards by removing illegal restriction sites. Our construct can be placed under the control of an inducible or constitutive promoter, resulting in controlled or continuous production of PHB.</P><P>You can find our phaC1J4 operon (BBa_K2260001) on the iGEM Registry <A href="http://parts.igem.org/Part:BBa_K2260001">here</A>.</P><H2>Experiments</H2><H3><B>Vector Experiments</B></H3><P>We ordered linear DNA inserts from IDT. The inserts are listed as follows:</P><P><UL><LI>phaC1<SUB><I>P. aeruginosa</I></SUB>J4<I><SUB>P. putida</SUB></I></LI><LI>fadE</LI><LI>fadD</LI></UL></P><P>We performed restriction enzyme digestion to ligate the inserts listed above with pET29b(+) vectors and transform into <I>E. coli</I>. Digestion confirmations were performed and the gel electrophoresis results were used to confirm the correct ligation of the vectors. Once the parts were confirmed via restriction enzyme digest and gel electrophoresis, we validated these parts through sequencing.</P><H3><B>PHB Production</B></H3><P>To synthesize PHB, we grew overnight cultures of our transformed <I>E. coli</I>BL21(DE3) for approximately 24 hours. These cells were then inoculated in flasks and supplemented with M9 media that contained different chemicals. A chemical extraction procedure was then performed on these cells to purify PHB from the cells. </P><H3><B>PHB Analysis</B></H3><P> PHB was digested with sulfuric acid and analysed by High-Performance Liquid Chromatography (HPLC). The HPLC chromatograms were compared to that of industrial-grade PHB. </P><H3><B>Protein analysis</B></H3><P>SDS-PAGE was performed on the pET29b(+)-phaCJ to confirm the expression of the gene after induction with IPTG because our construct was under a T7 inducible promoter. </P><P>Detailed results of the protocols for our experiments can be found on our <A href="https://2017.igem.org/Team:Calgary/Experiments">Experiments</A> page.
</P><H2>Results</H2><H3><B>Vector Experiments</B></H3><P>We successfully ligated and transformed the phaC1<SUB><I>P. aeruginosa</I></SUB>J4<I><SUB>P. putida</SUB></I> insert into pET29b(+) to produce pET29b(+)-phaCJ.</P><H3><B>PHB Production</B></H3><P>The <I> E. coli</I> transformed with the ligated pET29b(+)-phaCJ part produced visible amounts of PHB.</P><H3><B>PHB Analysis</B></H3><P>The HPLC results verified the identity of the PHB produced by the genetically engineered bacteria which contained pET29b(+)-phaCJ</P><H3><B>Protein analysis</B></H3><P>SDS-PAGE indicated that <I>phaCJ</I> was being expressed by the transformed <I>E. coli</I>. </P><P>Detailed results of these experiments can be found on our <A href="https://2017.igem.org/Team:Calgary/Results">Results</A> page and this part's <A href="http://parts.igem.org/Part:BBa_K2260001">Registry</A> page.</P><H2>Future Directions</H2><P>Due to time restraints, we were not able to explore the effect of <I>fadE</I> or <I>fadD</I> upregulation on PHB production via the  β-oxidation pathway. We would like to maximize the amount of PHB produced with our construct by adding <I>fadE</I> and <I>fadD</I> to the our phaCJ construct.This may produce more substrates for <I>phaJ</I> and <I>phaC</I> to convert into PHB. 
</P><P>We would also like to test out the effects of using constitutive promoters and compare them to the use of our IPTG-inducible T7 promoter by comparing the amount of PHB produced.</P><DIV class="apa-reference"><H2>Works Cited</H2><P>Lu, X., Zhang, J., Wu, Q. &amp; Chen, G.Q. (2003) Enhanced production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) via manipulating the fatty acid beta-oxidation pathway in <I>E. coli</I>. FEMS Microbiol Lett. 221: 97-101</P><P>Reyhanitash, E., Kersten, S. &amp; Schuur, B. (2017) Recovery of volatile fatty acids from fermented wastewater by adsorption. ACS sustainable Chemical Engineering. 5: 9176-9184</P><P>Rose, C., Parker, A., Jefferson, B. &amp; Cartmell, E. (2015). The characterization of feces and urine: a review of the literature to informed advanced treatment technology. Critical Reviews in Environmental Science Technology. 45: 1827-1879</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>